跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,164 条关于
“trastuzumab-deruxtecan”
全部
2,164
临床试验
1,546
药物
101
机构
1
资讯
516
去年
Meta-Analysis Confirms Trastuzumab Deruxtecan Efficacy in HER2-Positive Gastrointestinal Cancers
3个月前
Parexel Presents Real-World Safety Data on Trastuzumab Deruxtecan at ASCO 2026
3年前
Trastuzumab Deruxtecan Gains Regulatory Approvals in China and Europe for HER2-Positive Cancers
4年前
FDA Grants Breakthrough Therapy Designation to Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer
5个月前
Real-World Study Shows Trastuzumab Deruxtecan Improves Five-Year Survival in HER2-Positive Metastatic Colorectal Cancer
去年
Real-World Study Shows Safe Rechallenge with Trastuzumab Deruxtecan After Grade 1 Interstitial Lung Disease
去年
Trastuzumab Deruxtecan Combination Reduces Disease Progression Risk by 44% in HER2-Positive Metastatic Breast Cancer
去年
Trastuzumab Deruxtecan Shows Promise in HER2-Mutated NSCLC
去年
Trastuzumab Deruxtecan Shows Promise in HER2-Overexpressing NSCLC
10个月前
Mayo Clinic Identifies p95HER2 Protein as Key Driver of Resistance to Trastuzumab Deruxtecan in HER2+ Breast Cancer
第 1 页,共 52 页
上一页
下一页